Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Chronic activation profile of circulating CD8+T cells in Sezary syndrome

Full text
Author(s):
Show less -
Torrealba, Marina Passos [1] ; Manfrere, Kelly Cristina [1] ; Miyashiro, Denis R. [2] ; Lima, Josenilson F. [1] ; Oliveira, Luana de M. [1] ; Pereira, Natalli Z. [1] ; Cury-Martins, Jade [2] ; Pereira, Juliana [3] ; Duarte, Alberto J. S. [1] ; Sato, Maria N. [1] ; Sanches, Jose A. [2]
Total Authors: 11
Affiliation:
[1] Univ Sao Paulo, Med Sch, Med Invest Lab LIM 56, Dept Dermatol, Trop Med Inst Sao Paulo, Sao Paulo - Brazil
[2] Univ Sao Paulo, Med Sch, Dept Dermatol, Cutaneous Lymphoma Clin, Hosp Clin, Sao Paulo - Brazil
[3] Univ Sao Paulo, Med Sch, Hosp Clin, Hematol Dept, Sao Paulo - Brazil
Total Affiliations: 3
Document type: Journal article
Source: ONCOTARGET; v. 9, n. 3, p. 3497-3506, JAN 9 2018.
Web of Science Citations: 2
Abstract

Sezary syndrome (SS) is a leukemic variant of cutaneous T cell lymphoma (CTCL), and the neoplastic CD4+ T cells of SS patients undergo intense clonal proliferation. Although Sezary cells have been studied extensively, studies on adaptive immunity regarding CD8+ T cells are scarce. This study aimed to investigate activation marker expression in CD8+ T cells according to the differentiation stages and IL-7/IL7Ra axis responses of patients with SS. Moreover, this study aimed to verify the soluble forms of CD38, sCD127 and IL-7 in serum. Although the SS patients of our cohort had reduced numbers of CD8+ T cells, they exhibited higher percentages of CD8+CD38+T cells, mainly effector/memory CD8+ T cells, than the control group. In contrast, down-regulated expression of the activation markers CD127/IL-7R and CD26 was found in the CD8+ T cells of SS patients. High serum levels of sCD38 and sCD127 and scarce serum levels of IL-7 were detected, emphasizing the immune activation status of SS patients. Moreover, CD8+ T cells from SS patients exhibited IL-7 unresponsiveness to STAT5 phosphorylation and Bcl-2 expression, and IL-7 priming partially restored IFN gamma production. Our findings showed a chronic activation profile of CD8+ T cells, as an attenuated cytotoxic profile and impaired IL-7 responsiveness was observed, suggesting chronic activation status of CD8+ T cells in SS patients. (AU)

FAPESP's process: 14/04865-9 - Activation of cytotoxic response mediated by polyfunctional natural killer cells and t CD8+ cells induced by Toll-like-receptors agonists in the mycosis fungoides and Sézary syndrome
Grantee:José Antonio Sanches Junior
Support Opportunities: Regular Research Grants